348 related articles for article (PubMed ID: 28889240)
21. Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.
Guman MSS; Haal S; Acherman YIZ; van de Laar AWL; Nieuwdorp M; Voermans RP; Gerdes VEA
Obes Surg; 2023 Jun; 33(6):1773-1781. PubMed ID: 37186289
[TBL] [Abstract][Full Text] [Related]
22. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
[TBL] [Abstract][Full Text] [Related]
24. Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures.
Son SY; Song JH; Shin HJ; Hur H; Han SU
J Metab Bariatr Surg; 2022 Dec; 11(2):30-38. PubMed ID: 36926672
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid.
Coupaye M; Calabrese D; Sami O; Msika S; Ledoux S
Surg Obes Relat Dis; 2017 Apr; 13(4):681-685. PubMed ID: 28089591
[TBL] [Abstract][Full Text] [Related]
26. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
[TBL] [Abstract][Full Text] [Related]
27. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
Miller K; Hell E; Lang B; Lengauer E
Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
[TBL] [Abstract][Full Text] [Related]
29. Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis.
Tustumi F; Bernardo WM; Santo MA; Cecconello I
Obes Surg; 2018 Oct; 28(10):3312-3320. PubMed ID: 30097898
[TBL] [Abstract][Full Text] [Related]
30. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
[TBL] [Abstract][Full Text] [Related]
31. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.
Stokes CS; Gluud LL; Casper M; Lammert F
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1090-1100.e2; quiz e61. PubMed ID: 24321208
[TBL] [Abstract][Full Text] [Related]
33. Risk of cholecystectomy in morbidly obese patients after bariatric surgery in Taiwan.
Huang HH; Hsieh MS; Chen CY
Obes Res Clin Pract; 2019; 13(2):191-196. PubMed ID: 30665822
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
[TBL] [Abstract][Full Text] [Related]
35. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid.
Vural A; Goksu K; Kahraman AN; Boy FN; Anil BS; Fersahoglu MM
Acta Gastroenterol Belg; 2020; 83(1):33-38. PubMed ID: 32233269
[TBL] [Abstract][Full Text] [Related]
36. Bariatric surgery and prophylaxis against symptomatic gallstone disease.
Welbourn R; Pournaras DJ
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):972-973. PubMed ID: 34715030
[No Abstract] [Full Text] [Related]
37. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
Worobetz LJ; Inglis FG; Shaffer EA
Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
[TBL] [Abstract][Full Text] [Related]
38. How frequently and when do patients undergo cholecystectomy after bariatric surgery?
Tsirline VB; Keilani ZM; El Djouzi S; Phillips RC; Kuwada TS; Gersin K; Simms C; Stefanidis D
Surg Obes Relat Dis; 2014; 10(2):313-21. PubMed ID: 24462305
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.
Pineda O; Maydón HG; Amado M; Sepúlveda EM; Guilbert L; Espinosa O; Zerrweck C
Obes Surg; 2017 Jan; 27(1):148-153. PubMed ID: 27324135
[TBL] [Abstract][Full Text] [Related]
40. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
Ai T; Azemoto R; Saisho H
J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
